Clinical Trial Update: Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing repaglinide plus metformin versus repaglinide alone in patients with Type 2 diabetes who had not previously used oral glucose-lowering…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)
• Prandin (repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2010-12-08